Burkitt lymphoma in South African children: One or two entities?

Abstract Background There is insufficient research into the clinical presentation and outcome after treatment in children with Burkitt’s lymphoma (BL) who are also HIV infected, by comparison with those who are not infected. Patients and methods This retrospective study analyzed 15 HIV infected chil...

Full description

Saved in:
Bibliographic Details
Published in:Transfusion and apheresis science 2011-04, Vol.44 (2), p.191-194
Main Authors: Stefan, D. Cristina, Stones, D, Newton, R
Format: Article
Language:English
Subjects:
Adolescent
Anti-Retroviral Agents - pharmacology
Burkitt lymphoma
Burkitt Lymphoma - complications
Burkitt Lymphoma - epidemiology
Cancer
Child
Child, Preschool
Children
Female
Health technology assessment
Hematology, Oncology and Palliative Medicine
HIV
HIV Infections - complications
HIV Infections - epidemiology
Humans
Infant
Infant, Newborn
Male
Prognosis
Retrospective Studies
South Africa
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background There is insufficient research into the clinical presentation and outcome after treatment in children with Burkitt’s lymphoma (BL) who are also HIV infected, by comparison with those who are not infected. Patients and methods This retrospective study analyzed 15 HIV infected children with BL by comparison with 30 children with BL but not infected with HIV. These children were admitted consecutively in two South African hospitals from 1995 to 2004. The primary localization of the tumor, stage, treatment, relapse and overall survival were the main areas of interest. The distributions of studied variables in the two groups were tested for significance with statistic methods. Results The distribution by age, sex and stage of disease was not significantly different between the two samples. The primary site of tumor was, in both groups, more often in the abdomen than in the head, neck or other areas (53% of HIV positive cases and 80% of HIV negative cases). The chemotherapy protocol was in almost all cases LMB. The mortality ratio was significantly higher in the HIV positive group: 73% (11 out of 15 cases) versus 23% (7/30) – p = 0.002, while the length of follow-up was significantly shorter for the HIV infected children (average 30 months versus 48 months, p = 0.01). Conclusions The HIV infection worsens significantly the prognosis of children with BL, in spite of anti-retroviral and cytostatic treatment.
ISSN:1473-0502
1878-1683
DOI:10.1016/j.transci.2011.01.020